Cell-type-dependent activity of the ubiquitous transcription factor USF in cellular proliferation and transcriptional activation

Molecular and Cellular Biology

Volumn 19, Issue 2, 1999, Pages 1508-1517

  Qyang, Yibing ^a   Luo, Xu ^a,c   Lu, Tao ^a   Ismail, Preeti M ^a   Krylov, Dmitry ^b   Vinson, Charles ^b   Sawadogo, Michèle ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HELIX LOOP HELIX PROTEIN; HYBRID PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CELL PROLIFERATION; CELL TYPE; CELLULAR DISTRIBUTION; CONFORMATIONAL TRANSITION; DNA BINDING; GENE; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0032946220     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.2.1508     Document Type: Article

References (41)

1. Beckmann, H., L.-K. Su, and T. Kadesch. 1990. TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer μE3 motif. Genes Dev. 4:167-179.
2. 2 on specificity and comparison with binding of Myc family members. Nucleic Acids Res. 22:2801-2810.
3. Blackwell, T. K., L. Kretzner, E. M. Blackwood, R. N. Eisenman, and H. Weintraub. 1990. Sequence-specific DNA binding by the c-Myc protein. Science 250:1149-1151.
4. Blackwood, E. M., and R. N. Eisenman. 1991. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251:1211-1217.
5. Chandar, N., B. Billing, J. McMaster, and J. Novak. 1992. Inactivation of p53 gene in human and murine osteosarcoma cells. Br. J. Cancer 65:208-214.
6. Cogswell, J. P., M. M. Godlevski, M. Bonham, J. Bisis, and L. Babiss. 1995. Upstream stimulatory factor regulates expression of the cell cycle-dependent cyclin B1 gene promoter. Mol. Cell. Biol. 15:2782-2790.
7. Fisher, D. E., C. S. Carr, L. A. Parent, and P. A. Sharp. 1991. TFEB has DNA-binding and oligomerization properties of a unique helix-loop-helix/leucine-zipper family. Genes Dev. 5:2342-2352.
8. Gregor, P. D., M. Sawadogo, and R. G. Roeder. 1990. The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer. Genes Dev. 4:1730-1740.
9. Hemesath, T. T., E. Steingrimsson, G. McGill, M. J. Hansen, J. Vaught, C. A. Hodgkinson, H. Arnheiter, N. G. Copeland, N. A. Jenkins, and D. E. Fisher. 1994. microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev. 8:2770-2780.
10. Henrion, A. A., S. Vaulont, M. Raymondjean, and A. Kahn. 1996. Mouse USF1 gene cloning: comparative organization with the c-myc gene family. Mamm. Genome 7:803-809.
11. Ismail, P. M., and T. Lu. Unpublished observations.
12. Kaulen, H., P. Pognonec, P. D. Gregor, and R. G. Roeder. 1991. The Xenopus B1 factor is closely related to the mammalian activator USF and is implicated in the developmental regulation of TFIIIA gene expression. Mol. Cel. Biol. 11:412-424.
13. Kayto, E. N., H. M. Shih, and H. C. Towle. 1997. Carbohydrate regulation of hepatic gene expression - evidence against a role for the upstream stimulatory factor. J. Biol. Chem. 272:7525-7531.
14. Keegan, L., G. Gill, and M. Ptashne. 1986. Separation of DNA binding from the transcription-activating function of an eukaryotic regulatory protein. Science 231:699-704.
15. Kerkhoff, E., K. Bister, and K. H. Klempnauer. 1991. Sequence-specific DNA binding by Myc proteins. Proc. Natl. Acad. Sci. USA 88:4323-4327.
16. Kirschbaum, B. J., P. Pognonec, and R. G. Roeder. 1992. Definition of the transcriptional activation domain of recombinant 43-kilodalton USF. Mol. Cell. Biol. 12:5094-5101.
17. Koskinen, P. J., and K. Alitalo. 1993. Role of myc amplilication and over-expression in cell growth, differentiation and death. Cancer Biol. 4:3-12.
18. Kozlowski, M. T., L. Gan, J. M. Venuti, M. Sawadogo, and W. H. Klein. 1991. Sea urchin USF: a helix-loop-helix protein active in embryonic ectoderm cells. Dev. Biol. 148:625-630.
19. Krylov, D., D. Echlin, K. Kasai, H. Arnheiter, E. Taparowsky, and C. Vinson. 1997. A general method to design dominant negative to bHLHXZip proteins that abolish DNA binding. Proc. Natl. Acad. Sci. USA 94:12274-12279.
20. Krylov, D., M. Olive, and C. Vinson. 1995. Extending dimerization interfaces: the bZIP basic region can form a coiled coil. EMBO J. 14:5329-5337.
21. Land, H., L. F. Parada, and R. A. Weinberg. 1983. Tumorigenic conversion of primary fibroblasts requires at least two cooperating oncogenes. Nature 304:596-602.
22. Lin, Q., X. Luo, and M. Sawadogo. 1994. Archaic structure of the gene encoding transcription factor USF. J. Biol. Chem. 269:23894-23903.
23. Luo, X., and M. Sawadogo. 1996. Antiproliferative properties of the USF family of transcription factors. Proc. Natl. Acad. Sci. USA 93:1308-1313.
24. Luo, X. Unpublished observations.
25. Luo, X., and M. Sawadogo, 1996. Functional domains of transcription factor USF2: atypical nuclear localization signals and context-dependent transcriplional activation domains. Mol. Cell. Biol. 16:1367-1375.
26. Meier, J. L., X. Luo, M. Sawadogo, and S. E. Straus. 1994. The cellular transcription factor USF cooperates with varicella-zoster virus immediate-early protein 62 to symmetrically activate a bidirectional viral promoter. Mol. Cell Biol. 14:6896-6906.
27. Murre, C., P. S. McCaw, and D. Baltimore. 1989. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD and Myc proteins. Cell 56:777-783.
28. Olive, M., D. Krylov, D. R. Echlin, K. Gardner, E. Taparowsky, and C. Vinson. 1997. A dominant negative to activation protein-1 (AP1) that abolishes DNA binding and inhibits oncogenesis. J. Biol. Chem. 272:18586-18594.
29. Reisman, D., and V. Rotter. 1993. The helix-loop-helix containing transcription factor USF binds to and transactivates the promoter of the p53 tumor suppressor gene. Nucleic Acids Res. 21:345-350.
30. Sadowki, I., J. Ma, S. Triezenberg, and M. Ptashne. 1988. GAL4-VP16 is an unusually potent transcriptional activator. Nature 335:563-564.
31. Sadowski, I., and M. Ptashne. 1989. A vector for expressing Ga14(1-147) fusions in mammalian cells. Nucleic Acids Res. 17:7539.
32. Sawadogo, M., M. W. Van Dyke, P. D. Gregor, and R. G. Roeder. 1988. Multiple forms of the human gene-specific transcription factor USF. I. Complete purification and identification of USF from HeLa cell nuclei. J. Biol. Chem. 263:11985-11993.
33. Scholtz, B., M. Kingsley-Kallesen, and A. Rizzino. 1996. Transcription of the transforming growth factor-β2 gene is dependent on an E-box located between an essential cAMP esopnse clement/activation transcription factor motif and the TATA box of the gene. J. Biol. Chem. 271:32375-32380.
34. Schreiber, E., P. Matthias, M. M. Muhler, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with min-extracts prepared from a small number of cells. Nucleic Acids Res. 17:6419.
35. Schulman, I. G., C. Li, J. W. R. Schwabe, and R. M. Evans. 1997. The phantom ligand effect: allosteric control of transcription by the retinoid X receptor. Genes Dev. 11:299-308.
36. Shew, J. Y., B. T. Lin, P. L. then, T. L. Yang-Feng, and W. H. Lee. 1990. C-terminal truncation of the retinoblastoma gene product leads to functional inactivation. Proc. Natl. Acad. Sci. USA 87:6-10.
37. Sirito, M., S. Walker, Q. Lin, M. T. Kozlowski, W. H. Klein, and M. Sawadogo. 1992. Members of the USF family of helix-loop-helix proteins bind DNA as homo-as well as heterodimers. Gene Expr. 2:231-240.
38. Sirito, M., Q. Lin, T. Maity, and M. Sawadogo. 1994. Ubiquitous expression of the 43- and 44-kDa forms of transcription factor USF in mammalian cells. Nucleic Acids Res. 22:427-433.
39. Sirito, M., Q. Lin, J. M. Deng, R. R. Behringer, and M. Sawadogo. 1998. Overlapping roles and asymmetrical cross-regulation of the USF proteins in mice. Proc. Natl. Acad. Sci. USA 95:3758-3763.
40. Vallet, V. S., A. A. Henrion, D. Bucchini, M. Casado, M. Raymondjean, A. Kahn, and S. Vaulont. 1997. Glucose-dependent liver gene expression in upstream stimulatory factor 2 mice. J. Biol. Chem. 272:21944-21949.
41. Viollet, B., A. M. Lefrancois-Martinez, A. Henrion, A. Kahn, M. Raymondjean, and A. Martinez. 1996. Immunochemieal characterization and transacting properties of upstream stimulatory factor isoforms. J. Biol. Chem. 271:1405-1415.